<DOC>
	<DOCNO>NCT00730275</DOCNO>
	<brief_summary>This study ass safety , tolerability pharmacokinetics sitagliptin 10 17 year old diabetic patient .</brief_summary>
	<brief_title>A Study Assess Pharmacokinetics , Safety Tolerability Sitagliptin Adolescents ( 0431-081 )</brief_title>
	<detailed_description />
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Males females 10 17 year age History type 2 diabetes Nonsmoker No clinical laboratory evidence indicate diagnosis type 1 diabetes History diabetic ketoacidosis History stroke , chronic seizure major neurological disorder Consumes alcohol Consume 6 serving ( 1 serve approximately equivalent 120 mg caffeine ) coffee , tea , cola beverage contain caffeine per day Unable swallow tablet Has surgery , donate lose 1 unit blood , participate another investigational study within minimum 4 week prior start study History multiple and/or severe allergy allergic reaction significant intolerability prescription nonprescription drug food Currently regular user illicit drug history drug alcohol abuse History clinically significant endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary abnormality diseases Has estimate creatinine clearance less equal 80 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>